Nothing Special   »   [go: up one dir, main page]

Matsuki-Muramoto et al., 2017 - Google Patents

Bortezomib treatment prevents glomerulosclerosis associated with lupus nephritis in a murine model through suppressive effects on the immune and renin …

Matsuki-Muramoto et al., 2017

Document ID
7794999336103084888
Author
Matsuki-Muramoto Y
Nozawa K
Uomori K
Sekigawa I
Takasaki Y
Publication year
Publication venue
Modern Rheumatology

External Links

Snippet

Objective: To clarify the mechanisms underlying lupus nephritis (LN) amelioration following bortezomib treatment. Methods: Bortezomib was administered subcutaneously every 3 days to NZB/W F1 mice, and the serum anti-double stranded (ds) deoxyribonucleic acid (DNA) …
Continue reading at academic.oup.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Similar Documents

Publication Publication Date Title
Wilhelmson et al. Testosterone is an endogenous regulator of BAFF and splenic B cell number
Zouboulis et al. Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa
Chalmers et al. The CD6/ALCAM pathway promotes lupus nephritis via T cell–mediated responses
Nowling et al. Mechanisms of tissue injury in lupus nephritis
Lande et al. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA–peptide complexes in systemic lupus erythematosus
Kaplan Neutrophils in the pathogenesis and manifestations of SLE
Rupanagudi et al. Cathepsin S inhibition suppresses systemic lupus erythematosus and lupus nephritis because cathepsin S is essential for MHC class II-mediated CD4 T cell and B cell priming
Sidler et al. TWEAK mediates inflammation in experimental atopic dermatitis and psoriasis
Fujita et al. Regulation of S100A8 stability by RNF5 in intestinal epithelial cells determines intestinal inflammation and severity of colitis
Motwani et al. cGAS-STING pathway does not promote autoimmunity in murine models of SLE
Lui et al. Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice
Wang et al. Hassall’s corpuscles with cellular-senescence features maintain IFNα production through neutrophils and pDC activation in the thymus
Chen et al. Lipocalin-2 exacerbates lupus nephritis by promoting Th1 cell differentiation
Nishina et al. The effect of tocilizumab on preventing relapses in adult-onset Still's disease: a retrospective, single-center study
Germán et al. Disrupting the IL-36 and IL-23/IL-17 loop underlies the efficacy of calcipotriol and corticosteroid therapy for psoriasis
Brunner et al. CCL 7 contributes to the TNF‐alpha‐dependent inflammation of lesional psoriatic skin
Zhang et al. Effect of mycophenolate and rapamycin on renal fibrosis in lupus nephritis
Matsuki-Muramoto et al. Bortezomib treatment prevents glomerulosclerosis associated with lupus nephritis in a murine model through suppressive effects on the immune and renin–angiotensin systems
Mulders-Manders et al. Peri-and postoperative treatment with the interleukin-1 receptor antagonist anakinra is safe in patients undergoing renal transplantation: case series and review of the literature
Shimizu et al. Interferon-inducible Mx1 protein is highly expressed in renal tissues from treatment-naïve lupus nephritis, but not in those under immunosuppressive treatment
Wei et al. Genomic analysis of kidney allograft injury identifies hematopoietic cell kinase as a key driver of renal fibrosis
Bethunaickan et al. Anti–tumor necrosis factor α treatment of interferon‐α–induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation
Song et al. Neutralization of interleukin-17A alleviates burn-induced intestinal barrier disruption via reducing pro-inflammatory cytokines in a mouse model
Liang et al. Anti-TGF-β antibody, 1D11, ameliorates glomerular fibrosis in mouse models after the onset of proteinuria
Kaufmann et al. NLRP3 activation in neutrophils induces lethal autoinflammation, liver inflammation, and fibrosis